Mucosal antigen-specific T cells are pivotal for pathogen clearance and immune modulation in respiratory infections. Dysregulated T cell responses exacerbate coronavirus disease 2019 severity, marked ...
Approximately 15 to 20 million Americans who have acquired COVID-19 experience persistent symptoms lasting over 3 months (long-COVID). Respiratory symptoms of long-COVID include breathlessness, ...
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows. Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in ...
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows. Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in ...
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests return normal ...
What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells? Why would they do this? VIDO scientists based at the University of ...
This post continues from my previous article, which discusses the clinical differences between COVID-19 and the seasonal flu. These two diseases progress so differently because the viruses that cause ...
Prior to the study, some evidence suggested that inflammatory processes can awaken disseminated cancer cells (DCCs)—cells that have broken away from a primary tumor and spread to distant organs, often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results